Therapeutische Drug Monitoring van Tyrosine Kinase Inhibitoren: dicover more about the study and fill in the survey

Therapeutische Drug Monitoring van Tyrosine Kinase Inhibitoren: dicover more about the study and fill in the survey

The Belgian Hematology Society would like to kindly invite you to discover more and fill in the survey on Therapeutische Drug Monitoring van Tyrosine Kinase Inhibitoren. Find out more down below.

Dear Madam, Sir,


We are Catherine, Iemke, Lauren and Janne, four master’s students of Pharmaceutical Care at the Catholic University of Leuven, Belgium. We are writing our master’s thesis on the theme of ‘Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors’ (TDM of TKIs). In Belgium, TDM is not yet applied in routine care for TKIs, even though promising data is available, pointing towards TDM being a meaningful asset to TKI treatment. With this survey, we would like to gather expert opinions of Belgian health care professionals on TDM of TKIs, and why this would be (or not be) a meaningful asset to TKI treatment in routine care. This would be valuable information to support our thesis.


We would like to invite you to participate in this survey as an expert in this field. It will only take a few minutes of your time and will be deeply appreciated. This survey is fully anonymous and composed in English. Please do not forget to click the 'send’ button when you reach the end of the survey.

This survey will be available until the end of this month.


Discover more information Informatiebrief.pdf and fill in the survey HERE.


Thank you very much for your time.


Catherine Willems, Iemke Pyck, Lauren Olbrechts and Janne Goyens

Master’s students Pharmaceutical Care (KU Leuven, Belgium)